Logo image
Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)–Lung Study
Journal article   Open access   Peer reviewed

Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)–Lung Study

David J Lederer, Paul L Enright, Steven M Kawut, Eric A Hoffman, Gary Hunninghake, Edwin J. R van Beek, John H. M Austin, Rui Jiang, Gina S Lovasi and R. Graham Barr
American journal of respiratory and critical care medicine, Vol.180(5), pp.407-414
09/01/2009
DOI: 10.1164/rccm.200812-1966OC
PMCID: PMC2742759
PMID: 19542480
url
https://doi.org/10.1164/rccm.200812-1966OCView
Published (Version of record) Open Access

Abstract

Rationale : Cigarette smoking is a risk factor for diffuse parenchymal lung disease. Risk factors for subclinical parenchymal lung disease have not been described. Objectives : To determine if cigarette smoking is associated with subclinical parenchymal lung disease, as measured by spirometric restriction and regions of high attenuation on computed tomography (CT) imaging. Methods : We examined 2,563 adults without airflow obstruction or clinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis, a population-based cohort sampled from six communities in the United States. Cumulative and current cigarette smoking were assessed by pack-years and urine cotinine, respectively. Spirometric restriction was defined as a forced vital capacity less than the lower limit of normal. High attenuation areas on the lung fields of cardiac CT scans were defined as regions having an attenuation between −600 and −250 Hounsfield units, reflecting ground-glass and reticular abnormalities. Generalized additive models were used to adjust for age, gender, race/ethnicity, smoking status, anthropometrics, center, and CT scan parameters. Measurements and Main Results : The prevalence of spirometric restriction was 10.0% (95% confidence interval [CI], 8.9–11.2%) and increased relatively by 8% (95% CI, 3–12%) for each 10 cigarette pack-years in multivariate analysis. The median volume of high attenuation areas was 119 cm 3 (interquartile range, 100–143 cm 3 ). The volume of high attenuation areas increased by 1.6 cm 3 (95% CI, 0.9–2.4 cm 3 ) for each 10 cigarette pack-years in multivariate analysis. Conclusions : Smoking may cause subclinical parenchymal lung disease detectable by spirometry and CT imaging, even among a generally healthy cohort.
Computed Tomography cigarette smoking restrictive lung disease spirometry interstitial lung disease B. Chronic Obstructive Pulmonary Disease

Details

Metrics

Logo image